These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39112674)

  • 1. Animal models of pulmonary arterial hypertension associated with atrial septal defect.
    Wang L; Tang T; Tian X; Peng C; Wu S
    Sci Rep; 2024 Aug; 14(1):18287. PubMed ID: 39112674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of fenestrated atrial septal defect occulders on pulmonary hypertension dogs].
    Yang LF; Chen DD; Wang GF; Long YL; Jin QC; Kong DH; Pan WZ; Guan LH; Zhou DX; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Feb; 50(2):166-171. PubMed ID: 35172462
    [No Abstract]   [Full Text] [Related]  

  • 3. The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension.
    Huang ZW; Fan ZX; Sun JT; Li WM; Gao YQ; Quan YH; Geng YM; Niu YY; Wu BX
    Heart Vessels; 2012 Nov; 27(6):603-9. PubMed ID: 21927863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of right ventricular-pulmonary arterial coupling and pulmonary vascular resistance in adult patients with uncorrected atrial septal defect.
    Cool CJ; Khalid AF; Sukmadi N; Akbar MR; Setiabudiawan B; Rahayuningsih SE
    BMC Cardiovasc Disord; 2024 Jun; 24(1):297. PubMed ID: 38853261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An editorial regarding the article 'A meta-analysis of atrial septal defect closure in patients with severe pulmonary hypertension: is there a room for poking holes amidst debate?'.
    Sandeep B; Li H; Huang X; Xiao Z
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102172. PubMed ID: 37907187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Takaya Y; Akagi T; Sakamoto I; Kanazawa H; Nakazawa G; Murakami T; Yao A; Nanasato M; Saji M; Hirokami M; Fuku Y; Hosokawa S; Tada N; Matsumoto K; Imai M; Nakagawa K; Ito H
    Heart; 2022 Mar; 108(5):382-387. PubMed ID: 34415851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with congenital atrial septal defects: effect of age at repair and defect size on pulmonary artery pressures prior to repair.
    Motiwala A; Fatimi SH; Akhtar N; Perveen S; Khan MZ; Atiq M
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):281-6. PubMed ID: 21412709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway.
    Zhao X; Bai X; Li JL; Li SM; Xi J
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10532-10540. PubMed ID: 31841209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries.
    Peng X; Li HX; Shao HJ; Li GW; Sun J; Xi YH; Li HZ; Wang XY; Wang LN; Bai SZ; Zhang WH; Zhang L; Yang GD; Wu LY; Wang R; Xu CQ
    Mol Cell Biochem; 2014 Nov; 396(1-2):87-98. PubMed ID: 25063217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of preoperative oxygen saturation as a predictor of pulmonary arterial hypertension after surgery of atrial septal defects.
    Park HK; Shin HJ; Park YH; Ma BG
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):424-30. PubMed ID: 27222001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of dynamic pulmonary vascular resistance in two populations at risk of pulmonary arterial hypertension.
    Gabriels C; Lancellotti P; Van De Bruaene A; Voilliot D; De Meester P; Buys R; Delcroix M; Budts W
    Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):564-70. PubMed ID: 25525064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of the right heart and the preoperative factors that influence the emergence PAH after surgical closure of atrial septal defect.
    Supomo S; Widhinugroho A; Nugraha AA
    J Cardiothorac Surg; 2020 May; 15(1):105. PubMed ID: 32434521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
    Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
    Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
    Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
    J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inaccuracy of doppler echocardiographic estimates of pulmonary artery pressures in adult atrial septal defect patients with pulmonary arterial hypertension.
    Zhang C; Huang T; Huang X; Huang Y; Chen J; Chen J; Wu S; Zhuang J
    Chin Med J (Engl); 2014; 127(19):3389-95. PubMed ID: 25269902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
    Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
    Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meta-Analysis of Atrial Septal Defect Closure in Patients With Severe Pulmonary Hypertension: Is There a Room for Poking Holes Amid Debate?
    Cool CJ; Kamarullah W; Pranata R; Putra ICS; Khalid AF; Akbar MR; Setiabudiawan B; Rahayuningsih SE
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102121. PubMed ID: 37802163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nitric oxide inhalation on pulmonary arterial impedance: differences between normal and pulmonary hypertension male rats.
    Fukumitsu M; Kawada T; Nishikawa T; Yokota S; Matsushita H; Morita H; Sato K; Yoshida Y; Uemura K; Saku K
    Am J Physiol Heart Circ Physiol; 2024 Jul; 327(1):H000. PubMed ID: 38819383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.